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Methods and results: C57Bl/6 mice were submitted in vivo to left coro-
nary artery permanent ligature for different times (up to 21 days). After coro-
nary occlusion, intraperitoneal injection of Evasin-3 or Evasin-4 reduced the 
infarct size as compared to vehicle-treated control group. This bene¿ cial effect 
was associated with a decrease in myocardial leukocyte in¿ ltration and in cir-
culating levels of CXCL1 and CCL2. At 21 days, mouse survival and cardiac 
function were improved by treatments with Evasins as compared to vehicle.
Conclusion: In this study, we showed that treatments with Evasin-3 or 
Evasin-4 improved cardiac injury and remodeling in a mouse model of chronic 
myocardial ischemia. Therefore, Evasins might represent a promising thera-
peutic approach to reduce development of post-infarction heart failure in mice.
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Ono et al. (2005) have shown that delivery of Tat-BH4 peptide attenuates 
ischemia/reperfusion injury in Langerdorff-isolated rat hearts. BH4 peptide 
derivative from Bcl-xL protein prevents the opening of the mitochondrial 
permeability transition pore leading to caspase-3 activation (Shimizu et al,. 
2000). In a previous work, our lab demonstrated that inhibition of the Daxx-
dependent apoptosis pathway decreases infarct size and attenuates apoptosis 
(Roubille et al., 2007). At last, a recent work has shown in a cellular model 
that DAXX can reduce mRNA and protein levels of Bcl2 in vitro, and conver-
sely BCL2 can reduce mRNA and protein levels of Daxx (Muromoto et al., 
2010). Thus, we were interested in studying the effects of Tat-BH4 when 
injected in vivo on Daxx mRNA and protein levels in our surgical model of 
ischemia/reperfusion in mouse hearts. 40 min of ischemia are followed by one 
hour of reperfusion. A single intravenous injection of Tat-BH4 peptide (1 mg/
kg) 5 min before reperfusion prevented DNA fragmentation up to 66% in the 
ischemic part of mouse ventricles. This inhibition of apoptosis was associated 
with a decrease in infarct size up to 45%. This reduction of apoptosis was also 
associated to activation of caspase-3 assayed on western blots. Surprisingly, 
this single Tat-BH4 injection reduced signi¿ cantly the levels of DAXX pro-
teins in left ventricles compared to Tat-alone treatment. The DAXX-ASK1 
positive feedback loop plays an important role in amplifying JNK/p38 apop-
tosis pathways (Ichijo et al., 1997; Kitamura et al., 2009). Indeed, we observed 
that phosphorylation of JNK and p38 was signi¿ cantly reduced in Tat-BH4- 
compared to Tat-treated ischemic areas, and this was associated with an inhi-
bition of apoptosis. Our results reveal for the ¿ rst time in vivo a crosstalk 
between the anti-apoptotic Bcl-2 family and DAXX- pathways in ischemia/
reperfusion injuries in the mouse heart. 
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Objective: Cardiac ¿ broblasts (CF) are the largest cell population of the 
heart. We hypothesized that CF, may be implicated in endogenous paracrine 
cardioprotection against ischemia reperfusion (I/R) injury.
Method: Neonatal rat cardiomyocytes (NRC) and CF were isolated 
from 2 days old Wistar rats hearts and cultured separately. In a ¿ rst step, 
CF were submitted to 3H of simulated ischemia and their supernatant (SN) 
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Infarct size is a major determinant of myocardial functional recovery and 
mortality after acute myocardial infarction (AMI). Reperfusion injury culmi-
nates in apoptotic death of cardiac cells that were viable immediately before 
reperfusion. The aim of our study was to evaluate the cardioprotective effects 
of peptides interfering with Daxx and Bclx-L apoptotic pathways. 
Methods: DaxxP (inhibiting DAXX) and BH4 (anti-apoptotic) peptides 
were coupled to Cell Penetrating Peptides (CPPs, Tat and Pip2b) to improve 
their delivery to the myocardium.
C57Bl6 mice were subjected to a reversible ligature of the left coronary 
artery to induce in vivo IR injuries. After 40 min. of ischemia, the coronary 
artery was allowed to reperfuse (1 hour or 24 hours). Peptidic constructs 
(1mg/kg), were administered 5 min. before reperfusion. The control groups 
were treated by CPP alone. At the end of reperfusion, the coronary ligature 
de¿ nitively tighten, the blue dye injected and infarct size (TTC method) or 
DNA fragmentation measurements (Cell death ELISA kit, Roche) were mea-
sured in left ventricles.
Results: A single bolus of Tat-DaxxP and Pip2b-DaxxP (patent 
IB2010/003158) was able to decrease signi¿ cantly infarct size (on average 
55%-decrease) versus Tat or Pip2b peptides alone (p<0.01) (area at risk was 
comparable among groups; p=ns). This cardioprotection was as ef¿ cient as 
that offered by CPP-BH4 taken as positive control and was correlated to a 
drastic decrease in DNA fragmentation, a hallmark of apoptosis, in left ven-
tricles from CPP-DaxxP treated mice versus CPP-injected mice. The cardio-
protective effects of Tat-DaxxP and Pip2b-DaxxP were maintained when the 
reperfusion duration was prolonged from 1 hour to 24 hours.
Our ¿ ndings demonstrate that a bolus of CPP-DaxxP or -BH4 peptide 
conjugates promotes an anti-apoptotic effect in vivo, and imply that they may 
become useful therapeutic agents to reduce infarct size in AMI patients. 
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Background: Chemokine are known to trigger and direct leukocyte traf-
¿ cking from the blood stream towards inÀ amed tissues. They are implicated 
in several cardiovascular diseases, such as atherosclerosis, stroke, myocardial 
infarction and reperfusion injury. Chemokine-binding proteins (called Evasins) 
have been recently identi¿ ed from tick salivary glands and shown to inhibit 
chemokine-mediated leukocyte in¿ ltration. In this study, we investigated 
whether the anti-inÀ ammatory treatment with Evasin-3 (CXC chemokine inhi-
bitor) and Evasin-4 (CC chemokine inhibitor) could inÀ uence post-infarction 
myocardial injury and remodeling.
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Km is high and addition of creatine signi¿ cantly decreases Km, suggesting a 
high ef¿ ciency of the ANT-miCK functional coupling. Alterations in mito-
chondrial function in control and CsA groups were characterized by a signi-
¿ cant decrease in Km and partially loss of the stimulatory effect of creatine.
Conclusion: IPostC and CsA prevent the loss of integrity of the OMM 
after prolonged ischemia, moreover IPostC contribute to the preservation of 
the ANT-miCK functional coupling. 
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Chronic administration of orotic acid and its salts has been previously 
shown to protect the infarcted myocardium. The aims of the present study 
were: (i) to assess the effects of 1 mM magnesium orotate (Mg-Or) in acute 
administration at reperfusion post-global ischaemia on contractile function 
recovery and infarct size and (ii) to compare its effects with cardioprotection 
elicited by two classical strategies, ischaemic postconditioning (IPostC) with 
3 cycles of 30 seconds ischaemia/30 seconds reperfusion and pharmacological 
postconditioning with 0.2 M Cyclosporine A (CsA), respectively. Recovery 
of postischaemic ventricular function was assessed at 30 min of reperfusion by 
the left ventricular developed pressure (LVDP) and the maximal and minimal 
¿ rst derivatives of left ventricular pressure and (dP/dtmax and dP/dtmin) res-
pectively. Infarct size was quanti¿ ed at 2 h or reperfusion by the TTC staining. 
Mg-Or induced a signi¿ cant improvement in functional recovery compa-
rable to the one elicited by PostC and CsA for LVDP (Mg-Or  67.8±2,8%, 
IPostC 67.1±4.4%, CsA 62.8±3.2%  vs. controls 39.2±3.2%, p<0.001) and dP/
dtmax (Mg-Or 61.5±2.8%,  IPostC 72.4±1.7%, CsA 65.9±1.6% vs. Control, 
38.8±4.6%, p<0.001). In the case of dP/dtmin, a similar degree of cardio-
protection was obtain only for Mg-Or (72±4.5%) and IPostC (75.6±2.1%) vs. 
controls (47.6 ±4.6%, p<0.001).  Mg-Or and IPostC were also associated with 
an important antinecrotic effect at reperfusion (32.07±1.8% and 29.7±4.2% vs. 
controls, 70.4±3.7%, p<0.001).
In isolated rat hearts, acute administration of magnesium orotate at reperfu-
sion elicited a signi¿ cant improvement of the postischaemic contractile func-
tion and infarct size reduction comparable to the IPostC protection. 
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Myocardial ischemia and reperfusion lead to cardiomyocyte apoptosis. 
Caspases, a conserved family of proteases, are mainly involved in this cell 
death program. The initiator caspase, caspase-2, is the most conserved caspase 
among species. However, its role in cardiac reperfusion injury is unknown. 
The main goal of this study was to determine the role of caspase-2 in ischemia-
reperfusion. To this aim, we subjected rat neonatal cardiomyocytes to 3h of 
hypoxia + serum deprivation or serum deprivation followed by 1h, 3h, 6h, 24h 
or 48h of reoxygenation + serum supplementation (SS) or SS. Western blot 
analyses revealed that caspase-2 is expressed in ventricular cardiomyocytes of 
newborn rats. In addition, caspase-2 is cleaved after 3h of SS. Serum depletion 
is suf¿ cient to trigger this activation. Hypoxia did not induce additive effect. 
Flow cytometry analysis demonstrated that caspase-2 activation occurred after 
3h of SS. Although caspase-3 mRNA expression increased after 48h of SS, an 
increased level of mRNA encoding for caspase-2 and -8 is observed at 24h of 
SS. In vivo studies performed in adult rats showed that caspase-2 activity is 
increased at 1h of reperfusion (after 30 min of ischemia) while caspase-3 and 
was harvested. In a second step, NRC were also submitted to 3H of simu-
lated ischemia and SN of CF was added at reperfusion into NRC dishes at 
increasing doses (1X, 4X, 7X, 10X). At the end of reperfusion, MTT cell via-
bility assay was performed as well as troponin I measurement to quantify cell 
death.  In order to detect paracrine factors in SN of CF, a cytokine array was 
performed (n=4). Data are means±SEM. Comparisons between groups were 
performed by using 1 way ANOVA.
Results: We show that SN of CF protect NRC during I/R through a paracrin 
mechanism and this action seems to be effective in a dose response manner. 
Compared to isolated NRC alone, groups with SN of CF show an increase of 
50±10% viability at the most important doses of SN added. The cytokine array 
reveals that three cytokines were signi¿ cantly expressed (TIMP-1, CXCL-7 
and IFN-J) in CF secretome (see ¿ gure).
Conclusion: Our data suggest for the ¿ rst time, that CF may participate in 
endogenous cardioprotection against ischemia reperfusion injury. This protec-
tion may be mediated by paracrin mechanisms with a dose response pattern. 
Three potentially protective factors have been detected in CF secretome: 
TIMP-1, CXCL-7 and IFN-J.
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Introduction: This study investigate the effect of myocardial ischemic 
postconditioning (IPostC) and pharmacologic postconditioning by cyclospo-
rine A (CsA) on the changes in capacity of oxidative phosphorylation, and 
coupling between adenine nucleotide translocase (ANT) and mitochondrial 
creatine kinase (miCK).
Methods: Isolated perfused hearts from C57BL/6J mice were subjected to 
40-min of ischemia followed by 20-min of reperfusion (control group). Hearts 
were divided into 4 groups: 1) Control; 2) IPostC: elicited by ten cycles of 
5-s ischemia/5-s reperfusion after the 40-min ischemia; 3) CsA: administered 
during the ¿ rst min of reperfusion; 4) Sham: perfusion with normoxic condi-
tion (n=6 in each group). Parameters of mitochondrial function were assessed on 
saponin-skinned ¿ bers from isolated hearts. The protocol of the respiration rate 
determination included a cytochrome c test to check the intactness of the outer 
mitochondrial membrane (OMM). The apparent af¿ nity of the mitochondrial 
oxidative phosphorylation system for ADP (Km) in the presence and absence of 
creatine were also evaluated to test the ANT-miCK functional coupling.
Results: Our results show that the capacity of oxidative phosphorylation 
was signi¿ cantly reduced in control and CsA groups, and equivalent in IPostC 
group in comparison to Sham group. The cytochrome c test was negative 
in IPostC and CsA groups, suggesting intact OMM; and positive in control 
group, suggesting some alteration of the OMM. In Sham and IPostC groups, 
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Aims: To compare mechanisms of acute cardioprotective effect of IPost 
and RIPer and to determine whether combination of both strategies affords 
additional cardioprotection.
Methods: In open-chest rats, the left coronary artery (LAD) was occluded 
for 40 min and reperfused for 2 h. Rats were randomized to one of 4 groups: 
Control (n=6): no intervention at reperfusion; IPost (n=7): three cycles of 
10 sec LAD occlusion followed by 10 sec reperfusion applied at the onset of 
reperfusion; RIPer (n=7): 10 min limb ischemia followed by 10 min reperfu-
sion initiated 20 min after LAD occlusion; IPost+RIPer (n=7): combination of 
both IPost and RIPer.
Results: Both IPost and RIPer significantly decreased infarct size 
compared to Controls. IPost+RIPer was significantly more cardioprotec-
tive than IPost alone. Akt, ERK1/2 and GSK-3E phosphorylation were 
enhanced in IPost, RIPer and IPost+RIPer groups compared to Controls 
whereas none of these proteins was significantly more phosphorylated 
in IPost+RIPer than in IPost. IPost+RIPer highly increased phospho-
STAT-3 levels compared to IPost alone. PI3K/Akt inhibitor wortmannin 
and ERK1/2 inhibitor U0126 fully prevented cardioprotection induced by 
IPost, RIPer and IPost+RIPer. Blocking SAFE pathway by AG490 inhi-
bited both IPost and IPost+RIPer-induced cardioprotection. In IPost+RIPer 
group, GSK-3E phosphorylation was abolished in the presence of AG490 
and vice versa, STAT-3 phosphorylation was abolished in the presence of 
wortmannin or U0126, suggesting a possible cross-talk between RISK and 
SAFE pathways.
Conclusion: The combination of both IPost and RIPer affords additional 
cardioprotection, thought recruitment of both RISK and SAFE pathways. 
-9 are activated at 24h of reperfusion. Pharmacological inhibition using a pre-
ferential caspase-2 inhibitor (TRP601) 15 min prior to reperfusion reduced 
infarcted area by 50% and left ventricular remodeling after 15 days of reper-
fusion. These results indicate for the ¿ rst time that caspase-2 activation might 
play an important role in acute cardiac ischemia. Its activation occurs early 
in the apoptosis cascade suggesting that caspase-2 might be a potential thera-
peutic target in ischemia-reperfusion.
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Background: Ischemic postconditioning attenuates ischemia-reperfusion 
injury by activating prosurvival signalling pathways. The novel concept of 
remote ischemic perconditioning (RIPer), in which brief ischemia applied to 
an organ or tissue remote from the heart, is also cardioprotective.
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